United States · FDA National Drug Code directory

Lantus Solostar

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50090-1398_577365d4-f4cb-4431-9b05-a3d90efb7856
Product NDC
50090-1398
Form
INJECTION, SOLUTION
Composition / generic term
insulin glargine
Labeler
A-S Medication Solutions
Marketing category
BLA
Marketing start / end (source format)
20090923
Source listing expiry
20261231

Source-listed ingredients

  • INSULIN GLARGINE — 100 [iU]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 5 SYRINGE in 1 PACKAGE (50090-1398-0) / 3 mL in 1 SYRINGE · 50090-1398-0

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →